Page last updated: 2024-11-01

niclosamide and Parkinsonian Disorders

niclosamide has been researched along with Parkinsonian Disorders in 1 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barini, E1
Miccoli, A1
Tinarelli, F1
Mulholland, K1
Kadri, H1
Khanim, F1
Stojanovski, L1
Read, KD1
Burness, K1
Blow, JJ1
Mehellou, Y1
Muqit, MMK1

Other Studies

1 other study available for niclosamide and Parkinsonian Disorders

ArticleYear
The Anthelmintic Drug Niclosamide and Its Analogues Activate the Parkinson's Disease Associated Protein Kinase PINK1.
    Chembiochem : a European journal of chemical biology, 2018, 03-02, Volume: 19, Issue:5

    Topics: Anthelmintics; Drug Discovery; Enzyme Activators; HeLa Cells; Humans; Membrane Potential, Mitochondr

2018